Zobrazeno 1 - 10
of 59
pro vyhledávání: '"R.E. Bellet"'
Publikováno v:
Cancer. 36:1305-1308
A 77-year-old white man with 64 intracutaneous melanoma metastases and a pulmonary metastatic deposit was treated with immunotherapy. Over an 8-month period, 17 intracutaneous lesions were inoculated with BCG. All 17 injected lesions and all 47 uninj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f1b106493df298961abb7534fda2d8a
https://doi.org/10.1002/1097-0142(197510)36:4<1305::aid-cncr2820360417>3.0.co
https://doi.org/10.1002/1097-0142(197510)36:4<1305::aid-cncr2820360417>3.0.co
Autor:
D. D. Von Hoff, Marcel Rozencweig, Franco M. Muggia, J. S. Penta, R.E. Bellet, T.H. Wasserman
Publikováno v:
European Journal of Cancer (1965). 13:1293-1298
The human clinical pharmacology, toxicity and antitumor activity of ICRF-159 are reviewed. Phase II trials, multi-drug combinations and adjuvant trials are discussed in reference to the future study of this agent.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aadea2fa80223577e56da92eb778c2bb
https://doi.org/10.1016/0014-2964(77)90038-x
https://doi.org/10.1016/0014-2964(77)90038-x
Publikováno v:
European Journal of Cancer (1965). 14:793-797
Our previous studies demonstrated a lack of correlation between sequential lymphocyte reactivity and clinical tumor progression in patients with surgically incurable malignant melanoma. The purpose of the present investigation was to determine whethe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bf1f5d0992777333e6a1d30ca8e4ecd
https://doi.org/10.1016/0014-2964(78)90011-7
https://doi.org/10.1016/0014-2964(78)90011-7
Publikováno v:
Cancer. 40:1974-1981
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29d63d9308050800aaf91ce41ef43fdd
https://doi.org/10.1002/1097-0142(197710)40:4+<1974::aid-cncr2820400833>3.0.co
https://doi.org/10.1002/1097-0142(197710)40:4+<1974::aid-cncr2820400833>3.0.co
Publikováno v:
Cancer. 40:2091-2093
Eighteen patients with surgically incurable metastatic malignant melanoma were treated with a mixture of irradiated (15,000 rads) autologous tumors cells (1-2 X 10(8)) and BCG (Glaxo, 2-4.5 X 10(6) organisms), which was injected intradermally (in fiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57b17144432fb90c59172c5dcd1fb848
https://doi.org/10.1002/1097-0142(197711)40:5<2091::aid-cncr2820400517>3.0.co
https://doi.org/10.1002/1097-0142(197711)40:5<2091::aid-cncr2820400517>3.0.co
Publikováno v:
European journal of cancer. 15(2)
Eight surgically incurable melanoma patients receiving methyl-CCNU + vincristine + BCG + allogeneic melanoma cells, 8 receiving methyl-CCNU + vincristine, and 8 receiving only methyl-CCNU were measured for in vitro lymphocyte reactivity against an al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81a43ba0d53d24e05aac0e26ed9f66a6
https://pubmed.ncbi.nlm.nih.gov/436896
https://pubmed.ncbi.nlm.nih.gov/436896
Publikováno v:
Journal of clinical pharmacology. 16(8-9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c55b3364e7ed0b21fffdc749daf9baed
https://pubmed.ncbi.nlm.nih.gov/787016
https://pubmed.ncbi.nlm.nih.gov/787016
Publikováno v:
Cancer Immunology Immunotherapy. 6
Sixty-two patients with metastatic malignant melanoma were randomized to treatment with either (a) methyl-CCNU (200 mg/m2, PO every 8 weeks) plus vincristine (2 mg IV every 4 weeks), or (b) the same chemotherapy plus intradermal (ID) injections of ir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e8cf2d1ed95ade1860c2cd17f84482c
https://doi.org/10.1007/bf00200210
https://doi.org/10.1007/bf00200210
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.